BI-7273 is a potent and selective small molecule inhibitor primarily investigated for its role in cancer research. It functions by targeting specific signaling pathways involved in tumor cell proliferation and survival. Its main application lies in preclinical studies as a tool compound to modulate protein-protein interactions that drive oncogenic processes. Researchers use BI-7273 to probe the biological effects of inhibiting these interactions, particularly in cancers where conventional therapies show limited efficacy. Due to its high selectivity, it enables precise disruption of disease-related molecular mechanisms, making it valuable in validating therapeutic targets and guiding the development of new anticancer agents. Currently, its use remains confined to laboratory and experimental settings, supporting drug discovery and mechanistic studies in oncology.